QCG
EBS icon

Quadrant Capital Group’s Emergent Biosolutions EBS Stock Holding History

Quadrant Capital Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23
Closed -$191 – 1631
2026
Q1 		$191 Buy
+23
New +$238 ﹤0.01% 2667
2023
Q3 		– Sell
-25
Closed -$184 – 2707
2023
Q2 		$184 Sell
25
-1,341
-98% -$12.4K ﹤0.01% 2659
2023
Q1 		$14.2K Buy
1,366
+451
+49% +$5.45K ﹤0.01% 1862
2022
Q4 		$10.8K Buy
915
+299
+49% +$4.63K ﹤0.01% 1905
2022
Q3 		$13K Buy
616
+511
+487% +$14.2K ﹤0.01% 1758
2022
Q2 		$3K Sell
105
-26
-20% -$888 ﹤0.01% 2102
2022
Q1 		$5K Sell
131
-28
-18% -$1.24K ﹤0.01% 1901
2021
Q4 		$7K Sell
159
-63
-28% -$2.85K ﹤0.01% 1761
2021
Q3 		$11K Buy
222
+21
+10% +$1.27K ﹤0.01% 1526
2021
Q2 		$13K Sell
201
-98
-33% -$6.3K ﹤0.01% 1429
2021
Q1 		$28K Buy
299
+10
+3% +$1.02K ﹤0.01% 1028
2020
Q4 		$26K Buy
289
+63
+28% +$5.78K ﹤0.01% 991
2020
Q3 		$23K Sell
226
-1,989
-90% -$214K 0.01% 899
2020
Q2 		$175K Buy
2,215
+1,388
+168% +$103K 0.04% 291
2020
Q1 		$48K Buy
827
+38
+5% +$2.19K 0.01% 899
2019
Q4 		$41K Hold
789
– – ﹤0.01% 1433
2019
Q3 		$39K Buy
789
+740
+1,510% +$34.5K 0.01% 1322
2019
Q2 		$2K Buy
+49
New +$2.35K ﹤0.01% 2123
2016
Q3 		– Sell
-31
Closed – – 2015
2016
Q2 		$0 Hold
31
– – ﹤0.01% 1995
2016
Q1 		$1K Buy
+31
New +$1.09K ﹤0.01% 1482

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Quadrant Capital Group's EBS Position: Q2 2026 in Review

Quadrant Capital Group sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 23 shares — an estimated $191 sold.

Quadrant Capital Group first reported a position in EBS in Q1 2016 and held it in 20 quarters. The position peaked at $175K in Q2 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Quadrant Capital Group reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 23 Emergent Biosolutions shares in Q2 2026, an estimated $191.
  • Quadrant Capital Group first reported a position in Emergent Biosolutions in Q1 2016 and held it in 20 quarters.
  • Quadrant Capital Group's Emergent Biosolutions position peaked at $175K in Q2 2020.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.